Ra Capital Management, L.P. Eliem Therapeutics, Inc. Transaction History

Ra Capital Management, L.P.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2023 Feb 14, 2024	BUY	$2.45 - $2.85 $32.2 Million - $37.5 Million	13,150,849 New	13,150,849 $35.5 Million
Q3 2021 Nov 15, 2021	BUY	$14.45 - $28.61 $190 Million - $376 Million	13,150,849 New	13,150,849 $236 Million

3.7M

Ticker ELYM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,567,700
Market Cap $205M
Description
Eliem Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in chronic pain, neuropsychiatry, epilepsy, and other disorders of the peripheral and central nervous systems. Its two lead drug candidates are ETX-810 for chronic pain, which is in Phase II...

Get notified when there are updates to the investment portfolio of Ra Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Ra Capital Management, L.P. with notifications on news.